Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIA”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Not applicableStudy completedNCT03745508
What this trial is testing

Influence of Coffee Consumption on BIA-derived Body Composition Parameters

Who this might be right for
Healthy
University of Alberta 26
Not applicableStudy completedNCT03391206
What this trial is testing

Bioelectrical Impedance Utilization and Dietary Intake Relation in the Breast Cancer Related Lymphedema

Who this might be right for
Breast Cancer Lymphedemas
Severance Hospital 228
Not applicableStudy completedNCT05541068
What this trial is testing

Bioimpedance in Overweight and Obese Patients With Acute Heart Failure

Who this might be right for
Heart Failure
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 48
Early research (Phase 1)Study completedNCT00898560
What this trial is testing

Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 20
Early research (Phase 1)Study completedNCT03097211
What this trial is testing

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 38
Early research (Phase 1)Study completedNCT02171234
What this trial is testing

A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 32
Early research (Phase 1)Study completedNCT04675944
What this trial is testing

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 20
Not applicableStudy completedNCT06573567
What this trial is testing

Bioimpedance Analysis for Hemodialysis

Who this might be right for
Hemodialysis Complication
Cishan Hospital, Ministry of Health and Welfare 50
Early research (Phase 1)Study completedNCT03093389
What this trial is testing

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 40
Not applicableStudy completedNCT01379404
What this trial is testing

Bioimpedance Analysis in Septic Intensive Care Unit (ICU) Patients

Who this might be right for
Sepsis
St. Joseph's Healthcare Hamilton 55
Not applicableLooking for participantsNCT07196735
What this trial is testing

Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia

Who this might be right for
Functional DyspepsiaBIAFat Free Mass+2 more
Universitair Ziekenhuis Brussel 40
Not applicableStudy completedNCT02936440
What this trial is testing

Assessment of Hydration Status Using Bioelectrical Impedance Vector Analysis

Who this might be right for
Acute Kidney InjuryCritical Illness
Catholic University of Pelotas 224
Early research (Phase 1)Study completedNCT03099226
What this trial is testing

Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of BIA 5-453

Who this might be right for
Hypertension
Bial - Portela C S.A. 23
Early research (Phase 1)Study completedNCT02279667
What this trial is testing

Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 18
Not applicableLooking for participantsNCT06697470
What this trial is testing

Muscle and Subcutaneous Tissue Variation by Ultrasound and Impedance Linked to Fluid Balance in ICU Patients

Who this might be right for
Weakness Acquired in the ICUMuscle WastingEdema+3 more
Dr F Duprez 40
Early research (Phase 1)Study completedNCT02169466
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 22
Large-scale testing (Phase 3)Study completedNCT01568073
What this trial is testing

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 600
Large-scale testing (Phase 3)Study completedNCT00957372
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 253
Early research (Phase 1)Study completedNCT04991207
What this trial is testing

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 44
Early research (Phase 1)Study completedNCT02169895
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 16
Load More Results